Science in Person: Our experts make the difference

Published on November 3, 2025
Cellistic_Ft image_Our experts

At Cellistic, our people are at the heart of turning iPSC-derived cell therapies into clinical reality.
In this series, we meet the experts who make the difference — sharing their insights, challenges, and what drives them every day.

Continue reading on website
Other news

Where is the VA going in the next 5 years? 

November 3, 2025
The VA’s FY 2022–2028 Strategic Plan is built on four guiding principles – Access, Advocacy, Outcomes, and Excellence – and sets ambitious goals for modernization and service delivery by 2028: Deliver timely, accessible, and high-quality benefits, care, and services. Improve communication with Veterans and partners to strengthen trust and performance. Build and maintain trust among Veterans, careg

Bridging the Gap: Streamlining iPSC-Derived Cell Line Development from Donor Cells to MCB

November 3, 2025
Allogeneic iPSC-derived therapies hold immense promise, offering scalable, off-the-shelf solutions for a wide spectrum of diseases. However, the journey from donor cells to a gene edited, clinically compliant GMP Master Cell Bank (MCB) is fraught with challenges and is particularly vulnerable to risks stemming from misaligned early development.